Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Enhancement Strategies for Therapeutic Antibodies

Enhancing the avidity of mAbs would enable more effective therapies to be created - broadening the number of patients considered suitable for treatment and raising the possibility of resurrecting compounds that have failed in clinical development

Jeff Morhet (May 2008)

Keywords: Making mAbs better, Enhancing avidity, resurrecting compounds that failed in clinical development

    View full article    |    Back to Biopharma section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |